Manfred Schmidt

机构：Heidelberg University, National Center for Tumor Diseases, Comprehensive Cancer Center Erlangen, University College London, Brunel University of London · ORCID：0009-0001-9632-0599

发表论文 483 篇 · 总被引 36023 次 · h-index 83

代表论文

• Betibeglogene Autotemcel Gene Therapy for Non–β 0 /β 0 Genotype β-Thalassemia (2021 · New England Journal of Medicine · 被引 277)
• Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency (2021 · New England Journal of Medicine · 被引 225)
• Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease (2020 · Blood Advances · 被引 151)
• Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity (2021 · Immunity · 被引 133)
• Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB ‐206 study (2022 · American Journal of Hematology · 被引 126)
• Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial (2022 · Nature Medicine · 被引 105)